Automated Good Manufacturing Practice–compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines
Authors:
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 21 (11) , 1166-1178
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 643 (C1))
This publication has 60 references indexed in Scilit:
- Scale-up of human embryonic stem cell culture using a hollow fibre bioreactorBiotechnology Letters, 2012
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerCancer Immunology, Immunotherapy, 2012
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Factors determining the spontaneous activation of splenic dendritic cells in cultureInnate Immunity, 2010
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma†Hepatology, 2008
- Disruption of E-Cadherin-Mediated Adhesion Induces a Functionally Distinct Pathway of Dendritic Cell MaturationImmunity, 2007
- Dendritic cells in a mature ageNature Reviews Immunology, 2006
- Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic CellsJournal of Experimental Medicine, 2002
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.Journal of Experimental Medicine, 1995
- Proliferating dendritic cell progenitors in human blood.Journal of Experimental Medicine, 1994